Top Medical News

Brentuximab Vedotin Gets Green Light for High-Risk Hodgkin Lymphoma in Pediatric Patients

November 16th 2022

The FDA has approved brentuximab vedotin (Adcetris) in combination with doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide for pediatric patients with classical Hodgkin lymphoma.

Opinion: Post-Mastectomy Chest Numbness: Oncology Nurses Are Key to Patient Education

November 16th 2022

Oncology nurses are in a unique position to educate patients with breast cancer about post-mastectomy chest numbness.

Durvalumab/Tremelimumab/Chemotherapy Combination Approved for NSCLC Indication

November 15th 2022

The FDA has given the go-ahead to a combination of tremelimumab-actl (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for patients with non-small cell lung cancer and no EGFR mutations or ALK aberrations.

Mirvetuximab Soravtansine-gynx Gets Go Ahead in Platinum-Resistant Ovarian Cancer

November 15th 2022

Mirvetuximab soravtansine-gynx, an antibody drug conjugate, has received accelerated approval for platinum-resistant ovarian cancer. The prescribing label comes with warnings for visual toxicities, pneumonitis, and peripheral neuropathy.

Distress in Advanced Cancer May Be Alleviated With Psychedelic-Assisted Psychotherapy

November 15th 2022

Psychiatric distress and existential distress are associated with poor outcomes in patients with advanced cancers and treatment options such as psychotherapy have demonstrated limited effectiveness.


Most Recent